RION CO.,LTD. FY2027 Q1 Earnings Report

Quick View

Executive Summary

In Q1 of the fiscal year ending March 2027, Rion reported higher revenue and profit, with Operating Income increasing by double digits due to the decline in the SG&A ratio and an improved product mix in addition to revenue growth. Revenue was ¥68.8B (+3.9% YoY), Operating Income was ¥9.9B (+19.2%), Ordinary Income was ¥10.0B (+17.3%), and Net Income was ¥6.9B (+15.6%). The Operating Margin improved to 14.4% from 12.5% in the same period of the previous year. A slight increase in the gross margin, a decline in the SG&A ratio, and the Environmental Equipment segment's return to profitability contributed to the higher profit growth rate.

Factors Affecting Performance

【Revenue】Revenue was ¥68.8B (+3.9% YoY), with two of the three segments reporting revenue growth. Medical Equipment, the largest segment, increased to ¥30.6B (44.5% of total revenue, +5.5% YoY), while Environmental Equipment grew to ¥13.9B (20.2% of total revenue, +12.4%). In contrast, Particle Measurement Instruments, the core segment, declined to ¥24.4B (35.4% of total revenue, -2.3%). Growth in Medical Equipment and strong growth in Environmental Equipment offset the decline in Particle Measurement Instruments, securing overall revenue growth.

【Profit and Loss】Operating Income was ¥9.9B (+19.2% YoY), and the Operating Margin improved by approximately 1.8pt to 14.4% from 12.5% in the same period of the previous year. While the gross margin was essentially flat at 49.9% (49.6% in the previous year), the SG&A ratio declined to 35.5% (36.9% in the previous year), which was the primary driver of profit growth. Extraordinary losses consisted only of a loss on disposal of fixed assets of ¥0.01B, resulting in a limited impact from one-time factors. The difference between Ordinary Income and Net Income was attributable to the ordinary tax burden of ¥3.1B (tax rate: 31.2%), with no unusual adjustment items identified. In conclusion, the company reported higher revenue and profit.

Segment Analysis

Particle Measurement Instruments was the largest contributor to segment profit at ¥5.9B (59.2% of total segment profit), maintaining the highest profitability among the three segments with a margin of 24.0%. However, both revenue and profit in this segment declined from the previous year (revenue -2.3%, profit -5.6%), indicating somewhat slower short-term shipment momentum. Medical Equipment generated Operating Income of ¥2.9B (28.9% of total segment profit), with profit growth of +28.6% exceeding its revenue growth of +5.5%; its margin also improved to 9.3%. Environmental Equipment generated Operating Income of ¥1.2B (11.8% of total segment profit), returning to profitability from an Operating Loss of ¥0.1B in the same period of the previous year, with its margin recovering to 8.4%. While the core Particle Measurement Instruments segment continues to support overall profitability, profit growth in Medical Equipment and Environmental Equipment is contributing to improved stability across the portfolio.

Key Financial Indicators

【Profitability】The Operating Margin improved to 14.4% from 12.5% in the same period of the previous year, while the Net Profit Margin rose to 10.0% (9.0% in the previous year). The gross margin of 49.9% was essentially flat, and the primary driver of margin improvement was the decline in the SG&A ratio (35.5%, compared with 36.9% in the previous year). 【Cash Quality】Cash and deposits increased to ¥98.7B from ¥85.6B in the same period of the previous year, while the Equity Ratio remained high at 82.3% (83.3% in the previous year). 【Investment Efficiency】ROE was 2.0%, reflecting a level derived from a Net Profit Margin of 10.0%, total asset turnover of 0.16x, and financial leverage of 1.22x. The low total asset turnover is a constraint on capital efficiency. EPS was ¥55.79 (¥48.31 in the previous year, +15.5%). 【Financial Soundness】The current ratio was 497% and the quick ratio was 344%, securing substantial liquidity. The debt-to-equity ratio was low at 0.21x, indicating that the financial foundation is generally robust.

Cash Flow Analysis

As no cash flow statement has been disclosed, cash trends are assessed based on changes in the balance sheet. Cash and deposits increased by ¥13.1B to ¥98.7B from ¥85.6B in the same period of the previous year, suggesting that cash generation through operating activities has continued. Accounts receivable and notes receivable declined to ¥45.1B from ¥54.5B in the same period of the previous year, indicating improved receivables collection. Meanwhile, inventories were ¥79.7B, a slight increase from ¥78.4B in the same period of the previous year, suggesting that inventory levels remain elevated. Accounts payable increased to ¥18.1B from ¥16.4B in the previous year, while accrued expenses also increased substantially, with adjustments on the payment side providing a certain buffer for cash management. Overall, abundant liquidity on hand and low levels of interest-bearing debt support the funding base, while the potential for inventory reduction will be an issue for improving working capital efficiency going forward.

Quality of Earnings

Current-period profit consisted primarily of recurring earnings from operating activities. Extraordinary losses were extremely limited, consisting only of a ¥0.01B loss on disposal of fixed assets, and the impact of one-time factors on profit was minimal. Non-operating income was ¥0.4B, mainly consisting of ¥0.2B in dividend income, compared with non-operating expenses of ¥0.2B, including fees, leaving the net amount small. Comprehensive Income was ¥10.6B, exceeding Net Income of ¥6.9B by ¥3.7B. The difference was primarily attributable to market-related factors, including an increase of +¥2.9B in valuation difference on other securities and an increase of +¥1.0B in foreign currency translation adjustments. These are valuation-related fluctuations distinct from the company's recurring earnings power, and the quality of current-period earnings can be considered relatively strong because it is supported by an improvement in Operating Income from core operations.

Earnings Forecast and Guidance

Progress against the full-year plan in Q1 was 23.2% for Revenue, 21.0% for Operating Income, 21.1% for Ordinary Income, and 19.9% for Net Income, all below the 25% benchmark for simple equal quarterly progress. The full-year plan calls for Revenue of ¥297.0B (+4.2% YoY), Operating Income of ¥47.0B (+7.7%), and Ordinary Income of ¥47.5B (+6.9%). No revisions were made to the earnings or dividend forecasts for the current fiscal year. The below-benchmark progress rates are considered to reflect seasonality in shipments and orders due to the nature of the business. Achievement of the full-year plan will need to be assessed based on the trend in revenue progress over the coming quarters.

Shareholder Returns

The full-year dividend forecast is ¥45 per share, representing an increase of ¥10 from the previous fiscal year's actual dividend of ¥35. The Payout Ratio based on forecast EPS of ¥279.8 is approximately 16.1%, remaining at a conservative level. Given the financial foundation, including an Equity Ratio of 82.3% and cash and deposits of ¥98.7B, the company has strong capacity to secure funds for dividend payments.

Risk Factors

1. Demand Cycle Risk: Particle Measurement Instruments, the core segment, reported declines in both revenue and profit, with revenue down -2.3% and Operating Income down -5.6%. This suggests a business structure in which performance is susceptible to trends in clean-environment investment related to semiconductors, batteries, and other applications.

2. Working Capital Accumulation Risk: Inventories were ¥79.7B, a slight increase from the same period of the previous year, and persistently high inventory levels may weigh on cash efficiency. Accounts receivable declined to ¥45.1B, indicating improved collection, but progress in inventory reduction will be a key focus going forward.

3. Product Warranty and Quality Cost Risk: Current product warranty provisions were ¥3.0B, representing a certain proportion of Revenue. Costs related to after-sales services may limit further upside in profit margins.

Industry Benchmark (For Reference; Compiled by the Company)

Profitability and Returns

Both the Operating Margin and Net Profit Margin exceed the industry median, placing the company's profitability at a high level among its peers.

Growth and Capital Efficiency

The Revenue Growth Rate is below the industry median, indicating a relatively moderate level of top-line growth.

※Source: Compiled by the Company

Key Points from the Financial Results

1. Structural Drivers of Margin Improvement: The Operating Margin improved to 14.4% (12.5% in the previous year), supported by a stable gross margin and a decline in the SG&A ratio (35.5%, compared with 36.9% in the previous year). Progress in fixed-cost absorption is noteworthy when assessing the sustainability of profit growth during periods of revenue expansion.

2. Changes in the Segment Portfolio: Environmental Equipment returned to profitability from an Operating Loss in the same period of the previous year, while Medical Equipment achieved profit growth exceeding its revenue growth. In contrast, the core Particle Measurement Instruments segment reported declines in both revenue and profit. The simultaneous slowdown in growth of the highly profitable segment and recovery of non-core segments should be monitored as an indicator of future structural changes in the sources of earnings.

3. Capital Efficiency and Working Capital Levels: ROE remained at 2.0%, while total asset turnover was low relative to the substantial equity base represented by an Equity Ratio of 82.3%. Given the persistently high inventory level, working capital efficiency is a constraint on overall capital efficiency and should be considered when assessing the financial structure.

Theoretical Share Price (Reference Value)

This is a mechanically calculated reference range based solely on publicly disclosed data using a residual income model (Ohlson-type model with an explicit 5-year fade). It is not a forecast of the market share price or a recommendation to take any specific investment action.

Sensitivity: ¥2,851–¥3,023 at ±1% for the Cost of Equity, and ¥2,933–¥2,938 at ±0.1 for ω.

Notes:

• Net assets as of the end of the quarter are used (there is a timing mismatch with the full-year forecast).
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model / Interest Rate Reference Month: 2026-06 / This value does not forecast or guarantee the future share price)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings flash report data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with professionals as necessary.

---End of Report---